BrdU Labeling Reagent
Product Image
Invitrogen™

BrdU Labeling Reagent

Application: Labeling with BrdU in vivo or in cultured cellsRead more
Have Questions?
Catalog NumberQuantity
00010315 ml
Catalog number 000103
Price (TWD)
3,704.00
Online offer
Ends: 31-Mar-2026
4,630.00
Save 926.00 (20%)
Each
Add to cart
Quantity:
15 ml
Price (TWD)
3,704.00
Online offer
Ends: 31-Mar-2026
4,630.00
Save 926.00 (20%)
Each
Add to cart
Application: Labeling with BrdU in vivo or in cultured cells
For Research Use Only. Not for use in diagnostic procedures.
Specifications
Label or DyeBrdU
Quantity15 ml
Shipping ConditionWet Ice
Unit SizeEach
Contents & Storage
Store at 2°C to 8°C.

Frequently asked questions (FAQs)

What are the concentrations of the components in your BrdU Labeling reagent (Cat# 00-0103)?

Product 00-0103 contains BrdU (5-bromo-2'-deoxyuridine) and FrdU (5-fluoro-2'-deoxyuridine) at a molar ratio of 10:1. The concentrations of BrdU and FrdU in product are approximately 3 mg/mL and 0.3 mg/mL, respectively.

How long does the BrdU labeling reagent (Cat. No. 00-0103) last in cells? Can it last for 3-5 days?

The only study that we performed was in mice injected intraperitoneally with 10 uL of BrdU labeling reagent (catalog #00-0103) per gram of body weight. Incorporation of BrdU was monitored immunohistochemically only in the small intestine. Our data showed that 2-4 hours after BrdU injection in vivo was optimal for detection of staining in small intestine. Positive staining was lighter but still visible 8 hours later, but was gone after 24 hours.

With BrdU injection in mice, it is very unlikely that labeling, at least in small intestine, will last for 3-5 days. It is likely that the BrdU signal intensity as a function of time after labeling is species- and organ-specific, since the proliferation rate of the cells being labeled determines the amount of positive staining at any particular time. Also, labeling efficiency and kinetics are dependent upon the method used to label the cells in the sample with BrdU. For example, BrdU can be administered in vivo by injection, as described above, or by adding it to the animals' drinking water for several days. Labeling kinetics may vary for different types of cells in culture as well. For example, adherent cells typically label with different kinetics than cells that grow in suspension.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

Can I combine EdU and BrdU labeling and detection on the same sample?

Yes, EdU and BrdU labeling can be combined for dual-pulse labeling of cell proliferation in cultured cells and in vivo. BrdU will be preferentially incorporated into DNA, so perform the EdU incubation first followed by the BrdU incubation. Removal of EdU from the media is not required in cultured cells when BrdU is added as the second label. Perform an alcohol fixation followed by some method of DNA denaturation as required for the BrdU detection protocol and then perform the click labeling reaction for detection of EdU followed by antibody labeling for detection of BrdU. Be sure to select a BrdU antibody that does not have cross-reactivity to EdU, such as our MoBU-1 clone (Cat. No. B35141). Many BrdU antibodies have been shown to have some amount of cross-reactivity with incorporated EdU. Here is a link (http://www.thermofisher.com/us/en/home/references/protocols/cell-and-tissue-analysis/flow-cytometry-protocol/cell-proliferation/dual-pulse-labeling-of-cell-proliferation-using-edu-and-brdu-incorporation.html) to an example protocol for dual-pulse labeling using EdU and BrdU.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

Citations & References (1)

Citations & References
Abstract
Conditional expression of fibroblast growth factor-7 in the developing and mature lung.
Authors:Tichelaar JW, Lu W, Whitsett JA,
Journal:J Biol Chem
PubMed ID:10766812
Effects of fibroblast growth factor-7 (FGF-7) on lung morphogenesis, respiratory epithelial cell differentiation, and proliferation were assessed in transgenic mice in which the human FGF-7 cDNA was controlled by a conditional promoter under the direction of regulatory elements from either the human surfactant protein-C (SP-C) or rat Clara cell secretory ... More